Latest Research Associate Jobs

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and represents the asset to senior governance boards.

GSK Waltham, United States US$340,500 – US$567,500 pa

Hybrid

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and sets the asset strategy within GSK's oncology R&D portfolio.

GSK Stevenage US$340,500 – US$567,500 pa

Hybrid

Scientist, Cell-Based Screening (Photosynthesis Pathway and Enzyme Engineering)

Lead the development of a plant cell-based screening platform to evaluate carbon fixation, using quantitative methods and CRISPR-based genome editing in suspension cultures. Apply iterative design-build-test-learn cycles to identify improved photosynthesis enzyme variants and engineered pathways, advancing promising candidates into whole plants. Contribute to IP generation and collaborate across multidisciplinary teams.

Ellison Institute of Technology Oxford

On-site Permanent

Senior ML Infrastructure Engineer

Builds and operates high-performance GPU training and inference clusters, focusing on scheduling, isolation and automated lifecycle management. Optimises high-throughput data paths, I/O, caching and Lustre storage, and profiles bottlenecks across compute, network and orchestration layers. Works with research and data teams on capacity planning, quotas and ML experimentation pipelines.

Ellison Institute of Technology Oxford

Hybrid Permanent

Field Service Engineer, Medical Diagnostic Systems

Servicing, installing, repairing and calibrating laboratory diagnostics systems used in pathology departments, NHS labs and clinical chemistry settings, including flow cytometry and cell separation products. Field-based role requiring an electronics or electro-mechanical background and confident customer-facing skills, covering breakdowns and calibration at customer sites.

TRS Consulting Bromley £52,000 pa

Field Service Engineer, Medical Diagnostic Systems

Field Service Engineer, Medical Diagnostic SystemsOverall Earnings £65,000Basic Salary Up To £52,000Door To Door OvertimeOn Call Allowance10% BonusCompany Car (Electric Or Hybrid)PensionHealthcareLife InsurancePhone, LaptopHolidaysThe Role – Field Service Engineer, Medical Diagnostic SystemsThis market leader seeks to recruit a technically motivated...

TRS Consulting Newport £52,000 pa

Finance Portfolio Analytics Analyst

Builds and maintains financial and operational models, forecasts and dashboards that guide R&D portfolio and investment decisions, including NPV/rNPV, scenario and sensitivity analysis and Monte Carlo simulation. Works with the Head of Data Science and the Finance Portfolio Analytics Manager, turning scientific, clinical, financial and operational data into clear outputs for review discussions.

GSK London

Hybrid

Scientific Leader, Discovery Integration Sciences

Leads cross-functional teams designing, delivering and operating Lab-in-an-Automated-Loop systems that integrate computational intelligence with physical lab experimentation in adaptive learning cycles. Translates scientific requirements into system designs and platform capabilities, applying AI, agents and cloud-based workflow automation to accelerate medicine discovery. Hybrid role requiring on-site presence 2-3 days per week.

GSK USA - Pennsylvania - Upper Providence US$157,575 – US$262,625 pa

Hybrid

Director, Oncology Translational Medicine, Clinical Biomarkers

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Validates predictive, pharmacodynamic and resistance biomarkers using platforms such as NGS, ctDNA, flow cytometry and multi-omic analyses to inform dose selection and go/no-go decisions.

GSK USA - Pennsylvania - Upper Providence US$189,750 – US$316,250 pa

Hybrid

Director, Oncology Translational Medicine, Clinical Biomarkers

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Oversees biomarker assay development, sample testing plans and data packages across platforms such as NGS, IHC, flow cytometry and ctDNA, working with internal and external partners.

GSK London US$189,750 – US$316,250 pa

Hybrid

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Leads model-informed drug development for oncology programs, defining and executing model-based strategies from late discovery through lifecycle management. Conducts population PK, exposure-response, simulation-based trial design and dose selection, applying AI/ML, quantitative systems pharmacology and model-based meta-analysis. Presents to governance boards and regulators and works across matrix teams on small molecules, biologics and antibody drug conjugates.

GSK Waltham, United States £188,100 – £313,500 pa

Hybrid

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML and quantitative systems pharmacology methods, and defends results to governance boards and regulators. Sits within Oncology Translational Medicine's Clinical Pharmacology Modelling and Simulation group, working across small molecules, biologics and antibody drug conjugates.

GSK London £119,250 – £198,750 pa

Hybrid

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML, quantitative systems pharmacology and model-based meta-analysis to small molecules, biologics and antibody drug conjugates. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

GSK Wavre, Belgium €119,250 – €198,750 pa

Hybrid

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work across small molecules, biologics and antibody drug conjugates, applying AI/ML and quantitative systems pharmacology methods. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

GSK USA - Pennsylvania - Upper Providence US$188,100 – US$313,500 pa

Hybrid

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML and quantitative systems pharmacology methods, and defends results to governance boards and regulators. Sits within a matrixed Clinical Pharmacology Modelling and Simulation group working across small molecules, biologics and antibody drug conjugates.

GSK Durham, United States US$188,100 – US$313,500 pa

Hybrid